WO2002020509A3 - Arzneimittel gegen virale erkrankungen - Google Patents
Arzneimittel gegen virale erkrankungen Download PDFInfo
- Publication number
- WO2002020509A3 WO2002020509A3 PCT/EP2001/009772 EP0109772W WO0220509A3 WO 2002020509 A3 WO2002020509 A3 WO 2002020509A3 EP 0109772 W EP0109772 W EP 0109772W WO 0220509 A3 WO0220509 A3 WO 0220509A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hbv
- viral infections
- against viral
- medicaments against
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001289831A AU2001289831A1 (en) | 2000-09-06 | 2001-08-24 | Medicaments against viral infections |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10043791.5 | 2000-09-06 | ||
DE2000143791 DE10043791A1 (de) | 2000-09-06 | 2000-09-06 | Arzneimittel gegen virale Erkrankungen |
DE10054932.2 | 2000-11-06 | ||
DE2000154932 DE10054932A1 (de) | 2000-11-06 | 2000-11-06 | Arzneimittelkombinationen gegen virale Erkrankungen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002020509A2 WO2002020509A2 (de) | 2002-03-14 |
WO2002020509A3 true WO2002020509A3 (de) | 2002-06-27 |
Family
ID=26006936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/009772 WO2002020509A2 (de) | 2000-09-06 | 2001-08-24 | Arzneimittel gegen virale erkrankungen |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020082264A1 (de) |
AU (1) | AU2001289831A1 (de) |
WO (1) | WO2002020509A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008013428A (es) * | 2006-04-18 | 2008-11-04 | Abbott Lab | Antagonistas del receptor de vanilloides del subtipo (vr1) y usos de los mismos. |
ATE552262T1 (de) * | 2006-11-29 | 2012-04-15 | Pfizer Prod Inc | Spiroketone als inhibitoren von acetyl-coa- carboxylase |
PE20081559A1 (es) | 2007-01-12 | 2008-11-20 | Merck & Co Inc | DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA |
AU2008205642B2 (en) * | 2007-01-12 | 2013-06-06 | Msd K.K. | Spirochromanon derivatives |
HUE028983T2 (en) | 2010-05-06 | 2017-01-30 | Vertex Pharma | Heterocyclic chromene-spirocyclic piperidine amides as ion channel modulators |
CN102558126B (zh) * | 2010-12-16 | 2014-03-05 | 复旦大学 | 2-取代色原酮类化合物及其制备方法和用途 |
RS54785B1 (sr) | 2011-02-02 | 2016-10-31 | Vertex Pharma | Pirolopirazin-spirociklični piperidin amidi kao modulatori jonskih kanala |
JP5940562B2 (ja) | 2011-02-18 | 2016-06-29 | バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated | イオンチャネルのモジュレーターとしてのクロマン−スピロ環式ピペリジンアミド |
ES2618929T3 (es) | 2011-03-14 | 2017-06-22 | Vertex Pharmaceuticals Incorporated | Morfolina-Spiro piperidina amida cíclica como moduladores del canal iónico |
EP3126360A1 (de) | 2014-03-29 | 2017-02-08 | Lupin Limited | Sulfonamidverbindungen als spannungsabhängige natriumkanalmodulatoren |
CN104262317B (zh) * | 2014-09-04 | 2016-08-17 | 玉溪师范学院 | 一种二聚单萜类化合物及其制备方法与应用 |
CN107311973B (zh) * | 2017-06-25 | 2021-04-06 | 石家庄学院 | 一种含硝酸酯基二氢杨梅素衍生物及其制备和应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2611910A1 (de) * | 1976-03-20 | 1977-09-22 | Bayer Ag | Chromanone-(4) |
EP0004624A2 (de) * | 1978-04-07 | 1979-10-17 | Bayer Ag | Neue Chromanon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel und Wachstumsförderer |
WO1995030642A1 (en) * | 1994-05-06 | 1995-11-16 | Pharmacopeia, Inc. | Combinatorial dihydrobenzopyran library |
EP0695547A1 (de) * | 1993-04-09 | 1996-02-07 | Toyama Chemical Co., Ltd. | Immunomodulator, zelladhäsionsinhibitor und mittel zur behandlung und vorbeugung von autoimmunerkrankungen |
US6005103A (en) * | 1993-11-19 | 1999-12-21 | Warner-Lambert Company | Pyrone derivatives as protease inhibitors and antiviral agents |
US6046355A (en) * | 1996-11-01 | 2000-04-04 | Warner-Lambert Company | Dihydropyrones with improved antiviral activity |
-
2001
- 2001-08-24 WO PCT/EP2001/009772 patent/WO2002020509A2/de active Application Filing
- 2001-08-24 AU AU2001289831A patent/AU2001289831A1/en not_active Abandoned
- 2001-08-30 US US09/943,046 patent/US20020082264A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2611910A1 (de) * | 1976-03-20 | 1977-09-22 | Bayer Ag | Chromanone-(4) |
EP0004624A2 (de) * | 1978-04-07 | 1979-10-17 | Bayer Ag | Neue Chromanon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel und Wachstumsförderer |
EP0695547A1 (de) * | 1993-04-09 | 1996-02-07 | Toyama Chemical Co., Ltd. | Immunomodulator, zelladhäsionsinhibitor und mittel zur behandlung und vorbeugung von autoimmunerkrankungen |
US6005103A (en) * | 1993-11-19 | 1999-12-21 | Warner-Lambert Company | Pyrone derivatives as protease inhibitors and antiviral agents |
WO1995030642A1 (en) * | 1994-05-06 | 1995-11-16 | Pharmacopeia, Inc. | Combinatorial dihydrobenzopyran library |
US6046355A (en) * | 1996-11-01 | 2000-04-04 | Warner-Lambert Company | Dihydropyrones with improved antiviral activity |
Non-Patent Citations (4)
Title |
---|
CHIN-TENG CHANG ET AL.: "Coumarins and Anti-HBV constizuents from Zanthoxylum Schinifolium", PHYTOCHEMISTRY., vol. 45, no. 7, 1997, PERGAMON PRESS., GB, pages 1419 - 1422, XP004293278, ISSN: 0031-9422 * |
STEVE R. TURNER ET AL.: "Tipranavir(PNU-140690) A potent, Orally Bioavailable Nonpeptidic HIV protease inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class", JOURNAL OF MEDICINAL CHEMISTRY., vol. 41, no. 18, 1998, AMERICAN CHEMICAL SOCIETY., US, pages 3467 - 3476, XP002194391, ISSN: 0022-2623 * |
SUVIT THAISRIVONGS ET AL.: "Structure-based design of Hiv protease Inhibitors: 5,6-Dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY., vol. 39, no. 23, 1996, AMERICAN CHEMICAL SOCIETY., US, pages 4630 - 4642, XP002194392, ISSN: 0022-2623 * |
ZE-QI XU ET AL.: "In Vitro Anti-Human Immunodeficiency Virus Activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, no. 8, 1998, OXFORD, GB, pages 2179 - 2184, XP004137242, ISSN: 0960-894X * |
Also Published As
Publication number | Publication date |
---|---|
AU2001289831A1 (en) | 2002-03-22 |
US20020082264A1 (en) | 2002-06-27 |
WO2002020509A2 (de) | 2002-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001077091A3 (en) | Ns5b hcv polymerase inhibitors | |
ATE269321T1 (de) | Arzneimittel gegen virale erkrankungen | |
EP1653976A4 (de) | Anti-virale nucleosid-analoga und verfahren zur behandlung von virusinfektionen, insbesondere hiv-infektionen | |
WO2004011478A3 (en) | Anti-viral 7-deaza d-nucleosides and uses thereof | |
WO2002020509A3 (de) | Arzneimittel gegen virale erkrankungen | |
IL215891A (en) | Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections | |
WO2002057287A3 (en) | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | |
WO2007001406A3 (en) | Aryl-containing macrocyclic compounds | |
AU2002364730A1 (en) | N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections | |
WO2007049265A3 (en) | Anti mineralocorticoid therapy of infection | |
WO2006072625A8 (en) | Anti-kir combination treatments and methods | |
WO2004007512A3 (en) | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | |
WO2004000858A3 (en) | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | |
WO2004003138A3 (en) | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | |
WO2008003149A3 (en) | Substituted pteridines for the treatment and prevention of viral infections | |
WO2006101538A3 (en) | Andrographolide derivatives to treat viral infections | |
WO2003055896A3 (en) | Anti-viral 7-deaza l-nucleosides | |
AU2001232267A1 (en) | Remedies for hepatitis c | |
WO2005013917A3 (en) | Combination therapy for treating alphavirus infection and liver fibrosis | |
WO2001012228A3 (en) | Compositions for treating viral infections, and methods therefor | |
WO2003025139A3 (en) | Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof | |
WO2004052905A3 (en) | Antiviral nucleoside derivatives | |
WO2002000613A3 (en) | Inhibitors of hepatitis b virus infection | |
BR0108723A (pt) | Medicamentos contra doenças viróticas | |
WO2001097749A3 (en) | The use of synthetic, non-hormonal 21-aminosteroids and thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |